Pharmaceutical industry acquisitions could inhibit drug innovation and raise drug prices
By Hicbd
Fri Oct 11 2019 2:37 pm
"Six percent of the pharmaceutical industry’s acquisitions may not sound like much. But it translates into as many as 13 fewer new drugs per year that will never reach the consumer market. Moreover, killer acquisitions reduce competition, resulting in higher prices for existing drugs."
URL:----------------------------------------------------------
Please login to comment
